Physician

Michael Nathan Cohen, M.D.

According to 2025 Medicare claims, Michael Cohen, M.D. (NPI: 1699038935) practices ophthalmology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is RETINOVITREOUS ASSOCIATES LTD (NPI: 1659326452; TIN: 231932869) and primary practice location at 18301-8260.

Cohen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,551 traditional Medicare patients, billed 34,094 HCPCS/CPT codes, and received $4,610,655 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 993 prescription claims across 284 beneficiaries totaling $75,402 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 4 records totaling $17,738. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $11,914 to $4,610,655. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $31,741 to $75,402. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	64	111	$11,914
2017	153	204	$24,466
2018	835	6,401	$934,807
2019	1,092	12,574	$2,097,846
2020	1,057	8,884	$1,836,371
2021	1,252	11,497	$2,538,572
2022	1,568	15,981	$3,122,419
2023	1,542	25,578	$3,968,595
2024	1,551	34,094	$4,610,655

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	144	593	$31,741
2016	135	442	$29,150
2017	141	313	$23,751
2018	179	382	$49,446
2019	245	738	$84,427
2020	155	563	$68,534
2021	196	759	$95,707
2022	242	929	$109,315
2023	262	960	$120,830
2024	284	993	$75,402

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	292	3,152	$655
67028	Injection of drug into eye	519	2,750	$102
92014	Established patient complete exam of visual system	662	732	$92
92012	Established patient problem focused exam of visual system	779	2,414	$72
92134	Imaging of retina	1,495	4,363	$33

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prolensa	Bromfenac Sodium	42	1,475	$17,036
Difluprednate	Difluprednate	112	2,606	$10,851
Prednisolone Acetate	Prednisolone Acetate	167	7,620	$8,730
Bromfenac Sodium	Bromfenac Sodium	37	1,221	$7,943
Ilevro	Nepafenac	14	420	$5,168

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$249	Apellis Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$17,489	Alexion Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Nathan Cohen, M.D.?

Tedicare shows public-source Medicare data for Michael Nathan Cohen, M.D. (NPI 1699038935), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Nathan Cohen, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Nathan Cohen, M.D.?

Michael Nathan Cohen, M.D. is linked to RETINOVITREOUS ASSOCIATES LTD (billing NPI 1659326452) in the available physician profile data.

Does Michael Nathan Cohen, M.D. have Open Payments data?

Michael Nathan Cohen, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.